Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2010
08/25/2010EP2220069A1 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases
08/25/2010EP2220068A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
08/25/2010EP2220055A2 Novel heterocyclyl compounds and their use as chemokine antagonists
08/25/2010EP2220054A2 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
08/25/2010EP2220053A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists
08/25/2010EP2220052A1 Cyclic urea inhibitors of 11 -hydroxysteroid dehydrogenase 1
08/25/2010EP2220048A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/25/2010EP2220042A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
08/25/2010EP1994030B1 Multi-cyclic compounds and method of use
08/25/2010EP1910338B1 Heterotetracyclic compounds as tpo mimetics
08/25/2010EP1778676B1 Hydantoin derivatives for the treatment of inflammatory disorders
08/25/2010EP1742912B1 Novel androgens
08/25/2010EP1737844B1 Bicyclic anthranilamide derivatives useful as insecticides
08/25/2010EP1620082B9 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
08/25/2010EP1591443B1 Pyrazole derivative
08/25/2010EP1551834B1 Substituted quinazolinone compounds
08/25/2010EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1263722B1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
08/25/2010EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
08/25/2010CN1972917B Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
08/25/2010CN101815713A Polycyclic compound
08/25/2010CN101815712A Pyrazole compounds and their use as RAF inhibitors
08/25/2010CN101815711A Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
08/25/2010CN101815710A Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
08/25/2010CN101812097A Indole carbazole and bisindole maleimide alkaloid, preparation method and application thereof
08/24/2010US7781673 photovoltaic cell contains a photoactive copolymer with the first comonomer repeat unit cyclopentadithiophene moiety and the second comonomer repeat unit thienothiophene moiety; as charge carriers in the active layer of a photovoltaic cell
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781579 Cyclopentaphenanthrene-based compound and organic electroluminescent device using the same
08/24/2010US7781443 Tetrahydronaphthyridine derivatives and a process for preparing the same
08/24/2010US7781435 (S)-2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoic acid {1-[2-(3-ethoxy-propylamino) -ethyl]-1H-imidazol-4-yl}-amide, having beta-amyloid peptide production inhibitory activity, used for the treatment of neurodegenerative disorders such as Alzheimer's disease
08/24/2010US7781426 cholesterol ester transfer protein (CETP) inhibitors such as (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[2-(3,3-dimethylpiperidin-1-yl)-5-(trifluoromethyl)benzyl]-4-methyl-1,3-oxazolidin-2-one, useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis
08/19/2010WO2010093845A1 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
08/19/2010WO2010093787A2 Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
08/19/2010WO2010093727A1 Quinazolinones as prolyl hydroxylase inhibitors
08/19/2010WO2010093726A2 Large stokes shift dyes
08/19/2010WO2010093419A1 Novel amino azaheterocyclic carboxamides
08/19/2010WO2010093061A1 Diazepinedione derivative
08/19/2010WO2010092966A1 Novel triazine derivative and pharmaceutical composition containing same
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010092387A1 Process for preparation of bezoyl amino heterocyclyl compounds
08/19/2010WO2010092386A1 Crystalline polymorphic form 631
08/19/2010WO2010074607A3 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
08/19/2010WO2010056656A3 Preparation of crystalline palonosetron hydrochloride
08/19/2010WO2010045276A3 Azabenzimidazolones
08/19/2010WO2009122034A8 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
08/19/2010US20100210841 Chemical process 632
08/19/2010US20100210696 5-membered heterocyclic compound
08/19/2010US20100210673 Pyrimidylaminobenzamide derivatives for systemic mastocytosis
08/19/2010US20100210672 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
08/19/2010US20100210663 Hybrid 2-Aminotetralin and Aryl-Substituted Piperazine Compounds and their Use in Altering CNS Activity
08/19/2010US20100210662 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
08/19/2010US20100210659 Pyrrolidine derivatives as nk3 receptor antagonists
08/19/2010US20100210656 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210655 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210644 Chemical compounds
08/19/2010US20100210643 sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210629 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
08/19/2010US20100210628 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210627 Pyrazine compounds, their use and methods of preparation
08/19/2010US20100210623 Therapeutic compounds
08/19/2010US20100210620 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers
08/19/2010US20100210619 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210617 Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210467 Agent for improving sugarcane brix and method of promoting sugarcane ripening using the same
08/19/2010US20100209391 Novel inhibitors of hepatitis c virus replication
08/19/2010US20100209344 Radio-methyl Vorozole and Methods for Making and Using the Same
08/19/2010CA2789641A1 Diazepinedione derivative
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/19/2010CA2751886A1 Novel amino azaheterocyclic carboxamides
08/19/2010CA2749994A1 Crystalline polymorphic form 631
08/18/2010EP2218720A1 2-2'-Bis-thiazole derivatives as antiviral agents
08/18/2010EP2218718A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
08/18/2010EP2217593A1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor
08/18/2010EP2217592A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto
08/18/2010EP2217589A2 Modulators of ocular oxidative stress
08/18/2010EP2217580A2 Substituted tetrazole compounds and uses thereof
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP2076495B1 Quinoline derivatives with 5-ht-binding properties
08/18/2010EP1934203B1 3,4-dihydro-2H-benzo[1,4]oxazine and 3,4-dihydro-2H-benzo[1,4]thiazine COMPOUNDS AS ALPHA2C ADRENORECEPTOR AGONISTS
08/18/2010EP1874761B1 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
08/18/2010EP1758857B1 Indole derivatives as antiviral agents
08/18/2010EP1611107B1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN1795193B N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors
08/18/2010CN101809018A solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate
08/18/2010CN101809017A phthalazinone derivatives
08/18/2010CN101809016A Gamma secretase modulators
08/18/2010CN101809012A Spiro substituted compounds as angiogenesis inhibitors
08/18/2010CN101809001A Imidazole derivatives
08/18/2010CN101809000A Compounds with a combination of cannabinoid-CB1 antagonism and serotonin reuptake inhibition
08/18/2010CN101808693A Triazine kinase inhibitors
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101160128B Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 626